Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis
Alimentary Pharmacology & Therapeutics2018Vol. 48(6), pp. 671–681
Citations Over TimeTop 1% of 2018 papers
Wenwu Liu, Yun Zheng, Wei He, Ruhai Zou, Jiliang Qiu, Jingxian Shen, Zhiwen Yang, Yuanping Zhang, Chenwei Wang, Yongjin Wang, Dinglan Zuo, Binkui Li, Yunfei Yuan
Abstract
RFA is inferior to MWA for treating HCC within the Milan criteria, but has comparable efficacy to MWA for solitary HCC ≤ 3 cm.
Related Papers
- → Outcomes of Patients With Hepatocellular Carcinoma After Liver Transplant.(2015)3 cited
- → 1006 WHY IS RADIOFREQUENCY ABLATION THERAPY (RFA) APPLIED FOR HEPATOCELLULAR CARCINOMA (HCC) UP TO 3 NODULES AND SMALLER THAN 3 CM IN TUMOR SIZE?(2012)
- [Living donor liver transplantation for the patient with hepatocellular carcinoma].(2004)
- → Application status of radiofrequency ablation combined with different methods in the treatment of hepatocellular carcinoma(2011)